Our previous study demonstrated that pregnancy increased large-conductance Ca 2+ -activated potassium channel β1 subunit (BKβ1) expression and large-conductance Ca 2+ -activated potassium channel activity in uterine arteries, which were abrogated by chronic hypoxia. The present study tested the hypothesis that promoter methylation/demethylation is a key mechanism in epigenetic reprogramming of BKβ1 expression patterns in uterine arteries. Ovine BKβ1 promoter of 2315 bp spanning from −2211 to +104 of the transcription start site was cloned, and an Sp1 −380 binding site that contains CpG dinucleotide in its core binding sequences was identified. Site-directed deletion of the Sp1 site significantly decreased the BKβ1 promoter activity. Estrogen receptor-α bound to the Sp1 site through tethering to Sp1 and upregulated the expression of BKβ1. The Sp1 binding site at BKβ1 promoter was highly methylated in uterine arteries of nonpregnant sheep, and methylation inhibited transcription factor binding and BKβ1 promoter activity. Pregnancy caused a significant decrease in CpG methylation at the Sp1 binding site and increased Sp1 binding to the BKβ1 promoter and BKβ1 mRNA abundance. Chronic hypoxia during gestation abrogated this pregnancy-induced demethylation and upregulation of BKβ1 expression. The results provide evidence of a novel mechanism of promoter demethylation in pregnancy-induced reprogramming of large-conductance Ca 2+ -activated potassium channel expression and function in uterine arteries and suggest new insights of epigenetic mechanisms linking gestational hypoxia to aberrant uteroplacental circulation and increased risk of preeclampsia. (Hypertension. 2014;64:00-00.) • Online Data Supplement The online-only Data Supplement is available with this article at http://hyper.ahajournals.org/lookup/suppl/Original Article by guest on December 25, 2017 http://hyper.ahajournals.org/ Downloaded from by guest on December 25, 2017 http://hyper.ahajournals.org/ Downloaded from by guest on December 25, 2017 http://hyper.ahajournals.org/ Downloaded from by guest on December 25, 2017 http://hyper.ahajournals.org/ Downloaded from by guest on December 25, 2017 http://hyper.ahajournals.org/ Downloaded from by guest on December 25, 2017 http://hyper.ahajournals.org/ Downloaded from
T he striking increase of uterine blood flow in pregnancy is essential both for optimal growth and survival of the fetus and for cardiovascular well-being of the mother. Maladaptation of the uteroplacental circulation during pregnancy is associated with high incidence of clinical complications including preeclampsia and fetal intrauterine growth restriction. [1] [2] [3] [4] Thus, a comprehensive understanding of regulatory mechanisms of uterine vascular adaptation in pregnancy has long been sought but has not been achieved. The large-conductance Ca 2+activated potassium (BK Ca ) channel plays an essential role in determining the membrane potential of vascular smooth muscle cells and vascular tone. Previous studies demonstrated a critical role of BK Ca channels in the adaptation of uterine circulation and increased uterine blood flow in pregnancy. [5] [6] [7] The BK Ca channel is abundantly expressed in vascular smooth muscle cells and is a tetramer formed by a pore-forming α subunit (KCNMA1) along with ≤4 accessory β subunits. The predominant β subunit in vascular smooth muscle cells is the β1 subunit (KCNMB1), and other β subunits are either undetectable or negligible. 6, [8] [9] [10] [11] [12] [13] BK Ca channels in vascular smooth muscle are primarily activated by elevation of intracellular Ca 2+ concentrations, and the β1 subunit enhances Ca 2+ sensitivity of BK Ca channels. 10, [14] [15] [16] [17] The β1:α subunit stoichiometry is dynamic under various physiological and pathophysiological conditions and plays a vital role in regulating BK Ca channel activity in vascular smooth muscle. 9, 10, [14] [15] [16] [17] Recently, we and others have discovered that pregnancy and steroid hormones cause a significant increase in the β1, but not α, subunit, resulting in the increased β1:α subunit stoichiometry and heightened BK Ca channel activity in uterine arteries in sheep. 6, [18] [19] [20] In addition, chronic hypoxia during gestation abrogated these changes. 21 In ovine uterine arteries, both α and β1 subunits are detected exclusively in vascular smooth muscle cells with no evidence of their existence in the endothelium. 6, 18, 19 These previous electrophysiological and functional studies demonstrated an exciting and novel regulatory target of BKβ1 subunit in the adaptation of uterine vascular BK Ca channel activity in pregnancy. [5] [6] [7] 20, 21 However, the molecular mechanisms in regulating BKβ1 subunit expression remain unknown. Epigenetic mechanisms play an important role in regulating gene expression patterns and maintaining the homeostasis. DNA methylation is a principal mechanism in epigenetic modification of gene expression patterns and occurs
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September 2014 at cytosines of the dinucleotide sequence CpG. Methylation in promoter regions is generally associated with transcriptional repression of the associated genes. [22] [23] [24] [25] [26] [27] A recent study demonstrated that promoter methylation played a key role in regulating estrogen receptor-α (ERα) expression patterns in uterine vascular adaptation to pregnancy and chronic hypoxia. 28 Little is known about the epigenetic regulation of KCNMB1 gene expression patterns in vascular smooth muscle and its adaptation to pregnancy. Herein, we present evidence of a novel mechanism of promoter demethylation in pregnancy-induced reprogramming of BK Ca channel expression and function in uterine arteries and suggest new insights of epigenetic mechanisms linking gestational hypoxia to aberrant uteroplacental circulation and increased risk of preeclampsia. 16, 23 Uterine arteries were isolated from nonpregnant and near-term (≈140 days of gestation) pregnant sheep. Animals were anesthetized with thiamylal (10 mg/kg, IV) followed by inhalation of 1.5% to 2.0% halothane. An incision was made in the abdomen and the uterus exposed. The resistance-sized, fourth-generation branches of main uterine arteries were isolated and removed without stretching and placed into a modified Krebs solution. These arteries were used in all studies including vascular smooth muscle cell dissociation. For hormonal treatment, arteries from nonpregnant sheep were incubated in phenol red-free DMEM with 1% charcoal-stripped fetal bovine serum for 48 hours at 37°C in a humidified CO 2 incubator with 21% O 2 for tissues from normoxic animals and 10.5% O 2 for tissues from hypoxic animals in the absence or presence of 17β-estradiol (0.3 nmol/L; Sigma) and progesterone (100.0 nmol/L; Sigma), as reported previously. 20, 21 The concentrations of 17β-estradiol and progesterone chosen are physiologically relevant and have been shown to exhibit direct genomic effects on BK Ca channel function and pressuredependent myogenic tone in the uterine artery. 20, 21 All procedures and protocols were approved by the Institutional Animal Care and Use Committee and followed the guidelines by the National Institutes of Health Guide for the Care and Use of Laboratory Animals.
Materials and Methods

Tissue Preparation and Treatment
Real-Time Reverse Transcription PCR
Total RNA was isolated using TRIzol reagent (Invitrogen, CA) and subjected to reverse transcription with iScript cDNA Synthesis system (Bio-Rad, Hercules, CA). The abundance of KCNMB1 mRNA was measured with real-time polymerase chain reaction (PCR) using iQ SYBR Green Supermix (Bio-Rad), as described previously. 29 Primers used were 5′-CTGTACCACACGGAGGACACT-3′ (forward) and 5′-GTAGAGGCGCTGGAATAGGAC-3′ (reverse 
Reporter Gene Assay
Genomic DNA isolated from uterine arteries was used as a PCR template. Using primers designed from the bovine KCNMB1 gene promoter sequence (Gene ID, 407176), a 2315-bp ovine genomic fragment spanning −2211 bp to +104 bp relative to the KCNMB1 gene transcription start site was cloned into pCR4-TOPO vector and subsequently cloned in NheI-HindIII orientation in pGL3 basic vector (Promega, Madison, WI) to drive the transcription of the luciferase reporter gene. Site-specific deletion mutations were constructed at 2 putative transcription factor binding sites, AP1 −652 and Sp1 −380 , as described previously. 30 All promoter construct sequences were confirmed with DNA sequencing analyses. Smooth muscle cells were isolated from uterine arteries of control nonpregnant sheep and cultured in DMEM supplemented with 10% fetal bovine serum and 1% penicillin/streptomycin at 37°C in 95% air/5% CO 2 , as described previously. 28 Cells were grown and subcultured in 24-well plates with experiments performed at 70% to 80% confluence. Cells were transiently cotransfected with 1 μg of promoter/reporter vector along with 0.1 μg of internal control pRLSV40-Renilla Luciferase expression plasmid (Promega) vector using endotoxin-free plasmid DNA plus X-tremeGENE HP DNA Transfection Reagent (Roche) following the manufacturer's instructions. After 48 hours, firefly and Renilla reniformis luciferase activities in cell extracts were measured in a luminometer using a dual-luciferase reporter assay system (Promega), as described previously. 28, 30 The activities of the wild-type or site-specific deletion constructs were then calculated by normalizing the firefly luciferase activities to R reniformis luciferase activity and expressed as relative to wild-type reporter activity (% wild type).
Western Blot Analysis
Nuclear extracts were prepared from uterine arteries using NXTRACT CelLytic Nuclear Extraction Kit (Sigma, St Louis, MO). Protein concentrations were measured using a protein assay kit (Bio-Rad, Hercules, CA). Samples with equal amounts of protein were loaded onto 7.5% polyacrylamide gel with 0.1% SDS and separated by electrophoresis at 100 V for 90 minutes. Proteins were then transferred onto nitrocellulose membranes. Nonspecific binding sites were blocked for 1 hour at room temperature in a Tris-buffered saline solution containing 5% dry milk. The membranes were then probed with primary antibody against Sp1 (Active motif, Carlsbad, CA). After washing, membranes were incubated with secondary horseradish peroxidase-conjugated antibodies. Proteins were visualized with enhanced chemiluminescence reagents, and blots were exposed to Hyperfilm. Results were analyzed with the Kodak ID image analysis software.
Quantitative Methylation-Specific PCR
Genomic DNA was isolated from uterine arteries using a GenElute Mammalian Genomic DNA Mini-Prep kit (Sigma), denatured with 2N NaOH at 42°C for 15 minutes and treated with sodium bisulfite at 55°C for 16 hours, as previously described. 28, 31 DNA was purified with a Wizard DNA clean-up system (Promega) and dissolved in 120 μL of H 2 O. Bisulfite-treated DNA was used as a template for realtime fluorogenic methylation-specific PCR using specific primers designed to amplify the regions of interest with unmethylated CpG dinucleotides or methylated CpG dinucleotides (C m G), respectively ( Table S1 in the online-only Data Supplement). GAPDH was used as an internal reference gene. Real-time methylation-specific PCR was performed using the iQ SYBR Green Supermix with iCycler real-time PCR system (Bio-Rad). Data are presented as the percent of methylation at the region of interest (methylated CpG/methylated CpG+unmethylated CpG×100), as described previously. 28, 31 
Electrophoretic Mobility Shift Assay
Nuclear extracts were collected from uterine arteries using NXTRACT CelLytic Nuclear Extraction Kit (Sigma). The oligonucleotide probes with unmethylated CpG (forward: 5′-TGGCTGCTGGGCGGGTTGGAAATG-3′; reverse: 5′-CATTTCCAACCCGCCCAGCAGCCA-3′) and methylated C m G by guest on December 25, 2017 http://hyper.ahajournals.org/ Downloaded from (forward: 5′-TGGCTGCTGGG m CGGGTTGGAAATG-3′; reverse: 5′-CATTTCCAACC m CGCCCAGCAGCCA-3′) of the Sp1 −380 binding site at ovine KCNMB1 promoter region were labeled and subjected to gel shift assays using the Biotin 3′-end labeling kit and LightShift chemiluminescent electrophoretic mobility shift assay kit (Pierce Biotechnology, Rockford, IL), as described previously. 28, 31 Briefly, single-stranded oligos were incubated with terminal deoxynucleotidyl transferase and biotin-11-dUTP in binding mixture for 30 minutes at 37°C. The terminal deoxynucleotidyl transferase adds a biotin-labeled dUTP to the 3′-end of the oligonucleotides. The oligos were extracted using chloroform and isoamyl alcohol to remove the enzyme and unincorporated biotin-11-dUTP. Dot blots were performed to ensure that the oligos were labeled equally. Combining sense and antisense oligos and exposing to 95°C for 5 minutes were performed to anneal complementary oligos. The labeled oligonucleotides were then incubated with or without nuclear extracts in the binding buffer (from LightShift kit). Binding reactions were performed in 20 μL of reaction volume containing 50 fmol of oligonucleotide probes, 1× binding buffer, 1 μg of poly (dI-dC), and 5 μg of nuclear extracts. For competition studies, increasing concentrations of nonlabeled oligonucleotides were added to binding reactions. For supershift assays, 2 μL of affinity-purified Sp1 antibody (Active Motif) or ERα antibody (Thermo Scientific, Fremont, CA) was added to the binding reaction. The samples were then run on a native 5% polyacrylamide gel. The contents of the gel were then transferred to a nylon membrane (Pierce) and cross-linked to the membrane using a UV cross-linker (125 mJ/cm 2 ). Membranes were blocked and then visualized using the reagents provided in the LightShift kit.
Chromatin Immunoprecipitation (ChIP) and Re-ChIP
Chromatin extracts were prepared from uterine arteries. ChIP assays were performed using the ChIP-IT Express kit (Active Motif), as previously described. 28, 29 Briefly, tissues were exposed to 1% formaldehyde for 10 minutes to cross-link and maintain DNA/protein interactions. The reactions were stopped with glycine, tissues were washed, and chromatin were isolated and sheared into medium fragments (100-1000 bp) using a sonicator. ChIP reactions were performed using ERα or Sp1 antibodies to precipitate the transcription factor/DNA complex. Re-ChIP reactions were performed with re-ChIP kit (Active Motif) using an Sp1 antibody and then ERα antibody to precipitate the transcription factor/DNA complex. Cross-linking was then reversed, and proteins were digested with proteinase K. Primers flanking the SP1 −380 binding site were 5′-GTCAAAGGCTGAGGGTTTTG-3′ (forward) and 5′-GGAGGAGGAGTGGAAGCTCT-3′ (reverse). PCR amplification products were visualized on 2% agarose gel stained with ethidium bromide. For quantitative real-time PCR amplification, 45 cycles of real-time PCR were performed with 3-minute initial denaturation followed by 95°C for 30 s, 55°C for 30 s, and 72°C for 45 s, using the iQ SYBR Green Supermix with iCycler realtime PCR system (Bio-Rad).
Site-Directed CpG Methylation Mutagenesis and Reporter Gene Assay
The effect of site-directed CpG methylation on KCNMB1 promoter activity was determined as described previously. 23 Briefly, to determine the effect of methylation at Sp1 −380 on KCNMB1 promoter activity, 2 unique cutting sites were engineered at the Sp1 −380 site, with SacII at 5′ upstream and SmaI at 3′ downstream of the Sp1 −380 site. A customized 39-bp SacII/SmaI oligonucleotide fragment with methylation at CpG −383 was synthesized by Integrated DNA Technologies and ligated to the KCNMB1 promoter-reporter plasmid with pGL3. An identical 39-bp SacII/SmaI fragment with unmethylated CpG −383 at the Sp1 −380 site served as a control. The amount of formed ligation product was quantified by real-time PCR (forward primer: 5′-GTGACCTGCCTGGGGTCACA; reverse primer: 5′-GGGCTCATCAGCAGCTGGAG), and equal amount of plasmid was used in a transfection assay. Activities of each promoter-reporter constructs were determined as described above. The Sp1 −380 methylated or unmethylated oligo pairs used for in vitro methylation assay at the KCNMB1 promoter are listed as follows: Sp1-
Data Analysis
Data are expressed as mean±SEM. Statistical significance (P<0.05) was determined by ANOVA followed by Newman-Keuls post hoc test or Student t test, where appropriate.
Results
Pregnancy Upregulated KCNMB1 mRNA Expression in Uterine Arteries
Our previous studies demonstrated that pregnancy or steroid hormone treatment significantly increased KCNMB1 protein abundance in uterine arteries, which was inhibited by chronic hypoxia during gestation. 20, 21 Consistent with this finding, pregnancy and steroid hormone treatment significantly increased KCNMB1 mRNA abundance in uterine arteries ( Figure 1 ). However, in sheep acclimatized to long-term high-altitude hypoxia, pregnancy or steroid hormone-induced increase in KCNMB1 mRNA expression was abrogated ( Figure 1 ).
Sequencing of Ovine KCNMB1 Gene Proximal Regulatory Region
To investigate the mechanisms underlying this pregnancyinduced increase in KCNMB1 gene transcription, the proximal regulatory region upstream of the ovine KCNMB1 gene was cloned based on the bovine KCNMB1 proximal promoter sequences obtained from GenBank (Gene ID, 407176). As shown in Figure S1 , the sequence of this regulatory region consists of a 2315-bp ovine genomic fragment spanning from −2211 bp to +104 bp relative to the transcription start site. This regulatory region shows >90% homology to the bovine KCNMB1 promoter.
Pregnancy Decreased CpG Methylation at the Sp1 −380 Binding Site
Bioinformatics analysis of the ovine KCNMB1 promoter sequence identified several putative transcription factor binding sites that contained CpG dinucleotides in or near their core binding sequences, including Sp1 at −380 and AP1 at −652, −879, and −1202 ( Figure S1 ). CpG methylation patterns at these binding sites were determined by quantitative methylation-specific PCR. As shown in Figure 2 , CpG dinucleotides of these binding sites at KCNMB1 gene promoter were highly methylated in uterine arteries of nonpregnant sheep. Pregnancy selectively decreased CpG methylation at the Sp1 −380 binding site ( Figure 2 ). This pregnancy-mediated demethylation was not seen in uterine arteries from animals acclimatized to long-term high-altitude hypoxia (Figure 2 ).
Deletion of the Sp1 −380 Binding Site Inhibited KCNMB1 Promoter Activity
To determine the functional significance of Sp1 −380 binding site in regulating KCNMB1 promoter activity, reporter gene assay was performed with KCNMB1 promoter constructs containing site-directed deletion at the Sp1 −380 , and AP1 −652 sites in uterine 
CpG Methylation Blocked Sp1 Binding to KCNMB1 Promoter
Given that the Sp1 −380 binding site has a strong stimulatory effect on KCNMB1 promoter activity and that pregnancy selectively altered the methylation status at this binding site, our further investigation was focused on the Sp1 element. To evaluate Sp1 binding to the Sp1 −380 site at KCNMB1 promoter, we took the approach of electrophoretic mobility shift assay, with oligonucleotide probes encompassing the putative Sp1 −380 binding site. As shown in Figure 4A 
Pregnancy Increased Sp1 and ERα Binding to the Sp1 −380 Binding Site
Because pregnancy caused demethylation of the Sp1 −380 binding site in uterine arteries and gestational hypoxia abrogated this adaptation (Figure 2) , we determined the effect of pregnancy and chronic hypoxia on Sp1 and ERα binding to the Sp1 element at KCNMB1 promoter in vivo in the context of intact chromatin via ChIP assays. As shown in Figure 5 , pregnancy significantly increased both ERα and Sp1 binding at the Sp1 −380 site in uterine arteries. In contrast, in animals acclimatized to long-term high-altitude hypoxia, this pregnancyinduced increase of ERα and Sp1 binding was abolished ( Figure 5 ).
Methylation of Sp1 −380 Site Reduced KCNMB1 Promoter Activity
The functional significance of CpG methylation rendering the inhibition of Sp1/ERα binding to the promoter was further investigated by determining the effect of site-specific CpG methylation of the Sp1 −380 site on KCNMB1 promoter activity. To create a constitutive site-directed C m G at the Sp1 −380 site, 2 restriction enzyme sites, with SacII site at the 5′ upstream and SmaI site at the 3′ downstream of the Sp1 −380 site, were engineered in KCNMB1 promoter-luciferase reporter gene constructs. As shown in Figure 6 , the insertion of SacII and SmaI sites had no significant effect on the promoter activity compared with the wild-type KCNMB1 promoter. However, the C m G at the Sp1 −380 site significantly reduced the KCNMB1 promoter activity ( Figure 6 ).
Pregnancy Increased Sp1/ERα Binding Affinity to the Sp1 −380 Site
In addition to regulating promoter methylation, we determined whether pregnancy affected Sp1/ERα binding affinity to the Sp1 −380 site. In both normoxia control and hypoxic animals, no significant difference in nuclear Sp1 protein abundance was observed in uterine arteries between pregnant and nonpregnant sheep ( Figure S2 ). To determine the binding affinity of Sp1/ERα to the Sp1 −380 site, competition electrophoretic mobility shift assay was performed in pooled nuclear extracts from uterine arteries in each group of animals, with increasing ratios of unlabeled/labeled oligonucleotides encompassing the Sp1 −380 site. In normoxia control sheep, pregnancy significantly increased the binding affinity of nuclear extracts to (Figure 7 ). However, in sheep acclimatized to long-term high-altitude hypoxia, no significant difference was observed in Sp1/ERα binding affinity between pregnant and nonpregnant animals (Figure 7 ).
Discussion
The previous electrophysiological and functional studies demonstrated that pregnancy and steroid hormones induced a significant increase in the BKβ1 subunit expression, resulting in the increased BK Ca channel activity in uterine arteries in sheep. [5] [6] [7] 20, 21 The present study provides evidence of a novel mechanism of promoter demethylation in pregnancy-induced reprogramming of increased BK Ca channel expression and function in uterine arteries. In addition, this pregnancyinduced adaptation is inhibited by chronic hypoxia during gestation. We had cloned the proximal regulatory region upstream of the ovine KCNMB1 gene based on the bovine KCNMB1 proximal promoter sequences before the ovine genome sequence was available at National Center for Biotechnology Information. The cloned ovine KCNMB1 promoter sequence is nearly identical to that in the ovine genome sequence and has >90% homology to the bovine KCNMB1 promoter. Both of them lack the canonical TATA-like element. Multiple Ap1 and Sp1 response elements were identified by bioinformatics analysis at both bovine and ovine KCNMB1 promoters, and these elements are located almost in the same region. Unlike the bovine Ap1 sites that lack the CpGs, the ovine Ap1 sites contain CpG dinucleotides within or close to their core binding sequences. In contrast, the Sp1 binding site identified is highly homologous among ovine (Sp1 −380 ), bovine (Sp1 −417 ), and human (Sp1 −387 ) KCNMB1 gene promoters, thus showing translational applicability.
The finding that both Sp1 and ERα antibodies caused supershifting of the DNA-protein complex formed from binding of uterine artery nuclear extracts with the double-stranded oligonucleotide probes containing the Sp1 element is intriguing and indicates a true ERα/Sp1 binding site at ovine KCNMB1 promoter. Similar findings were obtained in the Sp1 binding elements at ERα promoter in uterine arteries 28 as well as protein kinase C-ε promoter in the heart, 29 in which ERα bound to the Sp1 sites. Our previous study demonstrated that estrogen increased KCNMB1 protein abundance in uterine arteries. 20 In agreement with this finding, the present study demonstrated steroid hormone-induced increase in KCNMB1 mRNA expression. Given that ovine KCNMB1 promoter region contains no estrogen response element, the finding of ERα binding to the Sp1 site is of importance and provides a novel mechanism that estrogen may regulate KCNMB1 gene expression by binding of ERα to the Sp1 site through tethering to Sp1 at the KCNMB1 promoter. Several studies have demonstrated an alternative mode of activation by estrogen via interactions with other transcription factors, in addition to binding to estrogen response element. 32, 33 ER can interact with both Ap1 and Sp1 transcription factors and bind to their binding sites in regulating the expression of genes, including human creatine kinase B, c-myc, heat shock protein 27, and ovine estrogen receptor in the uterine arteries. 28, 34 In the present study, the cross-talk of ERα and Sp1 in binding to the Sp1 −380 response element at KCNMB1 promoter was further determined in vivo in the context of intact chromatin by chromatin reimmunoprecipitation assay in uterine arteries.
The functional significance of the Sp1 −380 binding element in the regulation of the ovine KCNMB1 gene expression was demonstrated by the finding that deletion of this site significantly decreased the KCNMB1 promoter activity. The importance of promoter Sp1 elements in mediating estrogen response to regulate gene expression has been demonstrated in several genes including estrogen-mediated regulation of ERα transcription in uterine arteries. This was demonstrated by the finding that the estrogen-induced increase in ovine ERα promoter activity in uterine arterial smooth muscle cells was abrogated by the deletion of the Sp1 binding site. 28 In the present study, we have shown that the CpG dinucleotide transcription factor binding sites at KCNMB1 gene promoter were highly methylated in uterine arteries of nonpregnant sheep, indicating a reduced expression of KCNMB1 and BK Ca channel activity in nonpregnant uterine arteries compared with uterine arteries from pregnant animals. 20 Given that ovine, similar to bovine, KCNMB1 gene promoter lacks a TATA-like element, the enrichment of CpGs found at the promoter suggests a rigorous regulation of KCNMB1 gene expression by methylation. In contrast to KCNMB1 gene, BK Ca α subunit gene promoter lacks GC box or Sp1 binding site, and its expression is not regulated by pregnancy or chronic hypoxia. 20, 21 Although the transcriptional regulation by DNA methylation is commonly observed in CpG islands located around the promoter region and is mediated by the methylation-specific binding of methylated CpG-binding proteins, 35, 36 CpG methylation of specific transcription factor binding sites can alter gene expression through changes in the binding affinity of transcription factors to promoters. [37] [38] [39] The present study provides several lines of evidence showing that CpG methylation at Sp1 −380 binding site suppresses transcription factor binding and KCNMB1 promoter activity. Thus, the finding that nuclear extracts from uterine arteries shifted oligonucleotides encompassing the Sp1 binding site with unmethylated CpG but failed to cause a shift with methylated CpG indicates that CpG methylation in a sequence-specific binding site may directly inhibit the transcription factor binding. Similar findings were obtained with Sp1 elements at ERα and protein kinase C-ε promoters. 28, 29 In addition, we demonstrated that the binding of Sp1 and ERα to the Sp1 −380 site was reduced in vivo in the context of intact chromatin in uterine arteries of nonpregnant animals that had higher levels of CpG methylation. Of importance, the functional significance of CpG methylation at the Sp1 −380 binding site in regulating KCNMB1 gene expression was demonstrated by site-specific methylation of KCNMB1 promoter selectively at Sp1 −380 site, showing that the mutation of C m G at the Sp1 binding site significantly decreased the promoter activity. In agreement with this finding, our previous studies have shown that site-specific methylation of Sp1 elements inhibits ERα and protein kinase C-ε promoter activities. 28, 40 These findings suggest a common mechanism of CpG methylation at Sp1 binding elements in regulating gene transcription.
The finding that pregnancy selectively decreased CpG methylation in the SP1 −380 binding site at KCNMB1 promoter is intriguing and suggests a highly novel mechanism of pregnancy-induced DNA demethylation in a sequencespecific manner at transcription factor binding elements in a promoter region. Thus, this pregnancy-mediated promoter demethylation increased Sp1/ERα binding to the Sp1 element and upregulated KCNMB1 gene expression in uterine arteries. Although the mechanisms of pregnancy-induced demethylation in uterine arteries remain to be determined, several recent studies have suggested a robust mechanism of ten-eleven translocation 1-3 proteins in active DNA demethylation, resulting in increased expression of associated genes in adult tissues both in vitro and in vivo. [41] [42] [43] [44] [45] [46] [47] [48] Estrogen was recently reported to induce active DNA demethylation on promoters of estrogen response genes. For example, the pS2 gene underwent a switch from repression to expression under the stimulation of estrogen, which was caused by cyclic rounds of active methylation and demethylation at its promoter. 49, 50 In the present study, we have shown that chronic hypoxia during gestation inhibits this pregnancy-induced promoter demethylation and abrogates pregnancy-mediated increase in Sp1/ERα binding and KCNMB1 gene expression in uterine arteries. Given the complexity of potential DNA demethylation mechanisms, separate studies are warranted and are currently ongoing to investigate how pregnancy induces KCNMB1 gene demethylation and how hypoxia inhibits this demethylation in uterine arteries. The finding that pregnancy increased the binding affinity of nuclear extracts to the Sp1 −380 site suggests that, in addition to inducing promoter demethylation, pregnancy also enhances Sp1/ERα binding to unmethylated Sp1 −380 site at KCNMB1 promoter. Gestational hypoxia did not alter maternal plasma estrogen levels but significantly suppressed ERα expression in uterine arteries, 28, 51 suggesting a possible cause in hypoxic abrogation of the pregnancy-induced adaptation. Of importance functionally, our previous studies demonstrated that pregnancy-and steroid hormone-induced upregulation of β1:α subunit stoichiometry significantly increased the BK Ca channel activity and decreased myogenic tone in uterine arteries, which was abolished by chronic hypoxia during gestation. 20, 21 
Perspectives
During gestation, uterine arteries undergo profound physiological adaptation to increase uterine blood flow both for optimal growth and survival of the fetus and for cardiovascular well-being of the mother. Yet, the molecular mechanisms for this adaptation remain largely elusive. The BK Ca channel plays a critical role in the adaptation of uterine circulation and increased uterine blood flow in pregnancy. The present investigation provides evidence of a highly novel mechanism of promoter demethylation at sequence-specific transcription factor binding sites in epigenetic upregulation of BK Ca channel expression and activity in uterine vascular adaptation to pregnancy. Of importance, the finding that chronic hypoxia inhibits this pregnancy-induced adaptation suggests a novel epigenetic mechanism linking gestational hypoxia to aberrant uteroplacental circulation. Given that impaired uteroplacental circulation in both humans and several animal models has been implicated in preeclampsia, 52, 53 the present findings may help improve the understanding of preeclampsia, although it is a human-specific disorder. In addition, because of the vital importance of BK Ca channel function in determining vascular tone in virtually all vascular beds and the extremely limited current knowledge in epigenetic regulation of BK Ca channel expression and activity in vascular smooth muscle in general, the present finding has a broad impact in comprehensive understanding of molecular mechanisms in regulating BK Ca channel activity and the homeostasis of vascular tone. 
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